Medicinal chemistry advances in neurodegenerative disease therapy: part 2.

about

Medicinal chemistry advances in neurodegenerative disease therapy: part 2.

Item

http://www.wikidata.org/entity/Q38669008

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Medicinal chemistry advances in neurodegenerative disease therapy: part 2.

@en

type

Item

label

Medicinal chemistry advances in neurodegenerative disease therapy: part 2.

@en

prefLabel

Medicinal chemistry advances in neurodegenerative disease therapy: part 2.

@en

P1476

Medicinal chemistry advances in neurodegenerative disease therapy: part 2.

@en

P2093

Rachel Coleby

http://www.w3.org/2001/XMLSchema#string

P2860

Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer's disease drug discovery.

Multitarget drug design strategy in Alzheimer's disease: focus on cholinergic transmission and amyloid-β aggregation.

α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.

3-(Benzyloxy)-1-(5-[18F]fluoropentyl)-5-nitro-1H-indazole: a PET radiotracer to measure acetylcholinesterase in brain.

Neurodegenerative drug discovery: building on the past, looking to the future.

P304

951-952

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC-2017-0099

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28632420

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration